Kliman Gilbert H has filed a notice to sell 2,500 shares of GLAUKOS Corp stock, valued at approximately $632,500. This transaction is significant as it highlights ongoing financial maneuvers within the surgical and medical instruments sector.

Background

GLAUKOS Corp, which operates under the Central Index Key 0001192448, is recognized in the surgical and medical instruments and apparatus industry. The company is incorporated in Delaware and has its fiscal year ending on December 31. Recently, it has been active in the market, as indicated by multiple filings, including a Form 4 on August 20, 2026, and another Form 144 on August 19, 2026.

What the Filing Says

The filing, dated November 4, 2026, indicates that Kliman Gilbert H, a director at GLAUKOS Corp, will sell the shares acquired through a stock option exercise. The filing states, "The nature of acquisition transaction is Stock Option Exercise." The shares are set to be sold on the New York Stock Exchange.

Impact

This sale may affect the market perception of GLAUKOS Corp, particularly among investors who track insider trading activities. The filing notes that there are 59,196,870 shares outstanding, indicating that this sale represents a small fraction of the total shares available.

What's Next

The filing does not say what happens next.